Medical Information
Ireland
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

European Medicines Agency (EMA) has issued a Conditional Marketing Authorisation (CMA) to permit use of the product COMIRNATY COVID-19 mRNA Vaccine for active immunisation to prevent COVID-19 caused by SARS-CoV-2 virus, in individuals 12 years of age and older.

COMIRNATY (COVID-19 mRNA vaccine)

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

COMIRNATY Quick Finder

Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event
Reporting of Adverse Events

Suspected adverse events should be reported to the Health Products Regulatory Authority (HPRA). Suspected adverse events can also be reported to Pfizer on 1 800 633 363.